IL10 and bacterial infectious disease with sepsis: The rapid decline in IL-10 (5-fold by Day 2 in bacteremia cases) demonstrated the biomarker’s limited kinetic utility, as shown by Doerflinger et al. (2021) [16], who emphasized the superiority of PCT’s increasing pattern over decreasing cytokine levels.